openPR Logo
Press release

Histone Deacetylase Inhibitors Market Key Players : Celgene, Acetylon Pharmaceuticals, Celleron Therapeutics, Envivo Pharmaceuticals, Novartis, Merck & Co., and Pfizer.

10-26-2018 10:23 AM CET | Health & Medicine

Press release from: Allied Market Research

The Histone deactylase inhibitor (HDAC) is a molecule that consists of different compounds that form a group of anticancer agents. The parent epigenetic market of HDAC is expected to grow at a CAGR of around 30% worldwide from 2013 to 2020. The factors driving this market are increase in cancer incidences, ongoing research and development for the treatment of cancer, other diseases, and the need to improve the effectiveness of new therapies. The major limitation of this market is reimbursement and uncertainty issues. The opportunities for this market are increase in collaborations and huge investments in manufacturing which will ensure significant growth.

Key market players of this market are, Celgene, Acetylon Pharmaceuticals, Celleron Therapeutics, Envivo Pharmaceuticals, Novartis, Merck & Co., and Pfizer.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-toc-and-sample/61

KEY BENEFITS:

• The report provides Market attractiveness analysis for the most attractive geographical region worldwide, and considers factors responsible for rapid growth in the regions.
• Various economic factors which are significant in determining market trend, buying decisions and market attractiveness are been analyzed for market estimation and forecasting
• The report evaluates the key factors of drivers, restraints and opportunities enabling strategic decision making with perceptive to identify potential market.
• The study also discusses various environmental and regulatory factors critical for the market growth.
• The analysis will support stakeholders such as manufacturers and distributors in identifying and capturing markets with high potential.

KEY MARKET SEGMENTS

GLOBAL MARKET BY, CLASS

• Class I HDACs
• Class II HDACs
• Class III HDACs

GLOBAL MARKET BY, APPLICATIONS

• Cancer
• Central Nervous System Disorders
• Other Diseases

GLOBAL MARKET BY, GEOGRAPHY

• Europe
• North America
• Asia - Pacific
• RoW

KEY AUDIENCES:

• Health care centers
• Research facilities
• Academic institutes
• Pharmaceutical companies

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Histone Deacetylase Inhibitors Market Key Players : Celgene, Acetylon Pharmaceuticals, Celleron Therapeutics, Envivo Pharmaceuticals, Novartis, Merck & Co., and Pfizer. here

News-ID: 1330978 • Views:

More Releases from Allied Market Research

Dancewear Market Trends to Witness Astonishing Growth ; to Reach USD 1.7 Billion by 2030
Dancewear Market Trends to Witness Astonishing Growth ; to Reach USD 1.7 Billion …
According to a new report published by Allied Market Research, titled, "Dancewear Market," The dancewear market size was valued at $1.1 billion in 2020, and is estimated to reach $1.7 billion by 2030, growing at a CAGR of 4.8% from 2021 to 2030. Dancewear is a type of clothing and footwear that comes in a variety of colors, fabrics, materials, sizes, and designs that are suitable for a certain range
Instant Coffee Market was valued at $32,926.0 million in 2022 and to grow at a CAGR of 6.4% by 2032
Instant Coffee Market was valued at $32,926.0 million in 2022 and to grow at a C …
The global instant coffee industry was valued at $32,926.0 million in 2022, and is projected to reach $60,739.8 million by 2032, registering a CAGR of 6.4% from 2023 to 2032. The rapid growth of instant coffee is attributed primarily to the increasing demand for quick beverage solutions. This surge is fueled by the preferences of the younger generation for instant beverages, as they seek a café-like experience within the confines of
Event Services Market to Reflect Growth Potential with a Highest CAGR of 7.6% from 2022 to 2031
Event Services Market to Reflect Growth Potential with a Highest CAGR of 7.6% fr …
Allied Market Research published a report, titled, "Event Services Market by Service (Strategy, Planning, Budget, and market Development, Communication and Logistics, Attendees Management and Engagement, Event Catering, Virtual or Hybrid Event Enabler, Location Rental, Others), by Event Type (Music Concert, Festivals, Sports, Exhibitions and Conferences, Corporate Events and Seminars, Others), by End User (Corporate, Sports, Education, Entertainment, Others), by Organization (Small and Medium Enterprises, Large Enterprises, Government Bodies and NGOs):
Eyelash Serum Market Still Has Room to Grow | Grande Cosmetics LLC, JB Cosmetics Group
Eyelash Serum Market Still Has Room to Grow | Grande Cosmetics LLC, JB Cosmetics …
According to a new report published by Allied Market Research, titled, "Eyelash Serum Market," The Eyelash Serum Market Size was valued at $752.10 million in 2020, and is estimated to reach $1.3 billion by 2031, growing at a CAGR of 5.7% from 2022 to 2031. There is an increase in number of social media users, owing to rise in internet penetration. Considering this, most key players in the eyelash serum

All 5 Releases


More Releases for HDAC

Key Factor Supporting Global Histone Deacetylase (HDAC) Inhibitors Market Develo …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Histone Deacetylase (HDAC) Inhibitors Market Size By 2025? The valuation of the histone deacetylase (hdac) inhibitors market has seen considerable expansion lately, projected to advance from $1.23 billion in 2024 to reach $1.32 billion by 2025, reflecting a consistent annual growth rate of 7.6% over
Rising Neurodegenerative Disorders Drive Growth In HDAC Inhibitors Market: Pivot …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Histone Deacetylase (HDAC) Inhibitors Market Size Growth Forecast: What to Expect by 2025? The market for histone deacetylase (HDAC) inhibitors has seen substantial growth in the last few years. The market is predicted to expand from a size of $1.23 billion in 2024 to $1.33 billion in 2025, with
HDAC Inhibitors Market Projected to Grow Significantly Through 2034 | DelveInsig …
The HDAC Inhibitors companies in the market include - Merck & Co., Bristol Myers Squibb, Celgene Corporation, Spectrum Pharmaceuticals, and Syndax Pharmaceuticals, among others. The HDAC inhibitor market has shown significant growth in recent years, driven by the increasing prevalence of several key indications commonly treated with HDAC inhibitors, growing research in epigenetics, and expanding applications beyond oncology. According to DelveInsight's comprehensive analysis, key pharmaceutical companies, including Merck & Co., Bristol
Key Trend Reshaping the Histone Deacetylase (HDAC) Inhibitors Market in 2025: Sh …
Which drivers are expected to have the greatest impact on the over the histone deacetylase (hdac) inhibitors market's growth? The increasing incidence of neurodegenerative diseases is expected to drive the growth of the histone deacetylase (HDAC) inhibitors market. Neurodegenerative disorders, such as Alzheimer's disease, involve the progressive degeneration of neurons, leading to cognitive and motor dysfunction. The rising prevalence of these disorders is due to aging, genetics, and environmental factors. HDAC
Histone Deacetylase (HDAC) Inhibitors Market 2022 | Detailed Report
The Histone Deacetylase (HDAC) Inhibitors research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the
HDAC Inhibitors Market - Increasing R&D activities for cancer is expected to boo …
Overview HDAC inhibitors are a kind of anti-cancer drug that works by causing cell cycle arrest, apoptosis, and death in cancer cells through non-epigenetic or epigenetic control. HDAC inhibitors (HDACi) are potential medicines that have already demonstrated promise in oncological applications such as cancer detection, treatment, and prognostic. Vorinostat (Merck & Co. Inc.) is a new medication that is used to treat epidermal T cell lymphoma as it progresses, relapses, or